[
    [
        {
            "time": "",
            "original_text": "欧普康视：二级以下医疗机构和视光中心可以申请角膜塑形镜零售许可证，用户在取得二级以上医疗机构验配处方后，可以在以上机构定制镜片",
            "features": {
                "keywords": [
                    "欧普康视",
                    "角膜塑形镜",
                    "零售许可证",
                    "视光中心",
                    "医疗机构"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "欧普康视：二级以下医疗机构和视光中心可以申请角膜塑形镜零售许可证，用户在取得二级以上医疗机构验配处方后，可以在以上机构定制镜片",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "欧普康视：视光中心是非医疗机构",
            "features": {
                "keywords": [
                    "欧普康视",
                    "视光中心",
                    "非医疗机构"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "眼科"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "欧普康视：视光中心是非医疗机构",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "欧普康视回应“定增方案进展”：尚处于证监会审核过程中",
            "features": {
                "keywords": [
                    "欧普康视",
                    "定增方案",
                    "证监会",
                    "审核"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "欧普康视回应“定增方案进展”：尚处于证监会审核过程中",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]